Diclofenac sodium Voltaren is a pain reliever used for arthritis.It belongs to a class of medications commonly called NSAIDs or nonsteroidal anti-inflammatory drugs.
Other medicines in this category include over-the-counter analgesics like aspirin,...
GSK, Aspen enter product divestment agreement GlaxoSmithKline has agreed to sell four products, Eltroxin, Lanoxin, Imuran and Zyloric, to a subsidiary of the South Africa-based pharmaceuticals group, Aspen Global for a cash consideration of $339 million.Aspen will own these...
GSK and Aspen enter product divestment agreement This press release is intended for business journalists and analysts/investors.Please note that this release may not have been issued in every market in which GSK operates.
GlaxoSmithKline (GSK) today announced that it has agreed to...
Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs (Business Day/All Africa Global Media via COMTEX News Network) -- SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would...
Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs (Business Day/All Africa Global Media via COMTEX News Network) -- SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would...
South Africa: Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would give Aspen (APN) a springboard to launch its products into the more...
Aspen pays R2,7bn for offpatent Glaxo drugs CAPE TOWN SAs biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKlines older, offpatent drugs for R2,7bn.The deal would give Aspen (APN) a springboard to launch its products into...
Aspen pays R2,7bn for offpatent Glaxo drugs The deal would give Aspen a springboard to launch its products into the more than 200 markets where Glaxo already sold these drugs.SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said on Monday that it has bought four...
GSK's Cervarix faces further delay in USA, deal signed with Aspen The chances of GlaxoSmithKlines Cervarix reaching the US market anytime soon have disappeared after the company said that it will be the end of 2009 at the earliest before the cervical cancer vaccine gets approved across the Atlantic.In a...
GlaxoSmithKline Sells 4 Products To Aspen Global For GBP170 Million Edited Press Release LONDON GSK will record the gain on this transaction in the quarter ended 30 June 2008 GSK's Chief Executive Andrew Witty 'Aspen is a well respected and fast growing pharmaceuticals group with an extensive branded generic...
GlaxoSmithKline to sell to sell 4 products to Aspen, FY EPS guidance unchanged LONDON (Thomson Financial) - GlaxoSmithKline Plc has announced it will sell four products to South African Aspen for 170 million pounds.Europe's biggest drugmaker has agreed to sell the non-US and non-Japan rights of Eltroxin, a thyroid...
Glaxo sells 4 drugs to Aspen for 170m pounds Aspen will own the four drugs in all major markets outside of the United States.LONDON (Reuters) - GlaxoSmithKline Plc has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings for 170 million pounds, the...
Aspen in deal over brands Aspen Pharmacare Holdings (APN) announced the conclusion of a deal by its wholly-owned subsidiary, Aspen Global Incorporated (Global), with GlaxoSmithKline (GSK), whereby Global has purchased the intellectual property rights to four post...
GlaxoSmithKline Sells 4 Products To Aspen Global For... (DJ) LONDON -(Dow Jones)- GlaxoSmithKline Monday said it had agreed to sell four products, Eltroxin, Lanoxin, Imuran and Zyloric to a subsidiary of the South African based pharmaceuticals group, Aspen Global Incorporated for GBP170 million...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON (Reuters) - GlaxoSmithKline Plc sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings for 170 million pounds, the world's second biggest drugmaker said on Monday.Shares in Aspen fell 3.2 percent to 30...
GlaxoSmithKline to sell to sell 4 products to Aspen, FY EPS guidance unchanged LONDON (Thomson Financial) - GlaxoSmithKline Plc has announced it will sell four products to South African Aspen for 170 million pounds.Europe's biggest drugmaker has agreed to sell the non-US and non-Japan rights of Eltroxin, a thyroid...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research, Stock Buzz) has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research, Stock Buzz) for 170 million pounds...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON, June 30 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research) for 170 million pounds ($339 million)...
